Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

DZNE_MRC_CIHR Cooperation: Milestone for Research on Neurodegenerative Diseases

11.06.2010
Representatives of the German Centre for Neurodegenerative Diseases (DZNE), the UK Medical Research Council (MRC) and the Canadian Institutes of Health Research (CIHR) today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases. The lack of common standards so far has made it difficult for researchers to compare and validate research results. At the signing of the agreement today, the representatives of the German, British and Canadian governments emphasized the importance of international cooperation in tackling the challenges presented by an aging society.

All three cooperation partners possess special expertise in various fields ranging from basic to clinical research. The DZNE can contribute special know-how in the area of biomarkers and clinical studies. Prof. Pierluigi Nicotera, Scientific Director and Chairman of the Executive Board at the DZNE, is thrilled that the institution can contribute to the effort:

“This cooperation is of great importance for German research on neurodegenerative diseases. We hope to be able to contribute our expertise to develop new strategies to preventing and curing these diseases.” Prof. Nicotera emphasised that common technological platforms and the international standardisation of approaches are crucial to facilitating the transfer of fundamental discoveries into patient benefits.

To ensure that the results are applied in clinics as soon as possible, the German Federal Ministry of Education and Research (BMBF) has tasked the DZNE with working closely with university hospitals all over Germany. “The DZNE has intensified research on neurodegenerative diseases in Germany, improved the coordination of efforts and ensured that research is aligned with the requirements of clinical practice,” said Dr Helge Braun, Parliamentary State Secretary at the BMBF. But he pointed out that international partnerships are needed to solve the scientific and clinical issues regarding dementia. “Therefore we wholeheartedly applaud the pooling of resources across borders. The partnership between the MRC, CIHR and DZNE sets new international standards,” State Secretary Braun said at the press conference in Berlin. The British and Canadian governments also support the partnership. The two countries were represented by Christopher MacLean, Commercial Counsellor at the Canadian embassy, and British Ambassador Sir Michael Arthur, who said: “I am delighted that the UK – represented by the Medical Research Council – is participating in this international partnership. In a time of increasingly aging societies, new preventative strategies and innovative therapies for the treatment of neurodegenerative diseases are becoming more and more important.”

The Medical Research Council has injected significant funding to neurodegenerative research since that this area was reorganised in 2008. “We welcome this exciting opportunity to join with aligned activities in Germany and Canada,” said Prof. Chris Kennard, Chair of the MRC Neurosciences and Mental Health Board. “It’s through first-class international partnerships such as this one that we will build on our knowledge base and accelerate our understanding to more rapidly combat these debilitating neurodegenerative diseases.” Prof. Kennard went on to say that the links between the respective centres of excellence will create an international network that will enable them to attract the best scientists, provide access to cutting-edge technologies, standardise methods and their application and promote the highest level of quality in international research. The MRC can contribute a wealth of experience in working with animal models. Even at the basic research stage, standardised models and methods are crucial to ensure that findings can be compared.

The CIHR conducts both basic and clinical research and is working to standardise imaging methods and the evaluation of the images they generate. “We are proud to work with our colleagues in Germany and the UK to fund research addressing neurodegenerative disorders, in particular on Alzheimer’s disease. We firmly believe that it will require a concerted common research effort to better understand these disorders, improve diagnosis and treatment, and ultimately find a cure for diseases that affect millions of people,” said Dr Rémi Quirion, Executive Director of the International Collaborative Research Strategy for Alzheimer's Disease at the Canadian Institutes of Health Research.

To reach their goals, each of the three centres will allocate 1 million pound. This will serve as starting capital to finance various measures in the three centres. In addition to workshops and the compilation of guidelines, the money will also be specifically used to fund projects in the centres that work according to these guidelines and methods and will advance the research field as a whole. Reactions to the initiative launched by the three partner institutions have been favourable in other countries, and negotiations are underway with other European research organisations.

The German Centre for Neurodegenerative Diseases belongs to the Helmholtz Association and is funded by federal and state governments in relation 90:10.

Common press release of the
Deutschen Zentrum für Neurodegenerative Erkrankungen e. V.
Medical Research Council
Canadian Institutes of Health Research
Contact:
Sonja Jülich-Abbas
DZNE Press and Public Relations
Tel.: +49 228 30899-225
Mobile: +49 172 283 8930
E-mail: sonja.juelich-abbas(at)dzne.de

Sonja Jülich-Abbas | idw
Further information:
http://www.dzne.de

More articles from Life Sciences:

nachricht Research team creates new possibilities for medicine and materials sciences
22.01.2018 | Humboldt-Universität zu Berlin

nachricht Saarland University bioinformaticians compute gene sequences inherited from each parent
22.01.2018 | Universität des Saarlandes

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Thanks for the memory: NIST takes a deep look at memristors

22.01.2018 | Materials Sciences

Radioactivity from oil and gas wastewater persists in Pennsylvania stream sediments

22.01.2018 | Earth Sciences

Saarland University bioinformaticians compute gene sequences inherited from each parent

22.01.2018 | Life Sciences

VideoLinks Wissenschaft & Forschung
Overview of more VideoLinks >>>